Pharmaceutical

Pan Cancer T raises funds through seed extension round

Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, PCT1:CO-STIM.

Jul 14, 2024 - 04:00
Pan Cancer T raises funds through seed extension round
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, PCT1:CO-STIM.
Read the original article

Tags:

Previous Article

FDA grants fast track designation to AskBio’s AB-1005 for PD

Next Article

Sorry, I didn’t get that: evaluating usability issues with AI-assisted smart spe...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ironwood Pharmaceuticals agrees to buy VectivBio for $1bn

Ironwood Pharmaceuticals agrees to buy VectivBio for $1bn

May 22, 2023

Opinion: How the government can help lower the price — not just the cost — of cutting-edge gene therapies

Opinion: How the government can help lower the price — ...

Nov 1, 2023

Pandemic slowed cancer diagnoses, but late-stage cancers came back with a vengeance

Pandemic slowed cancer diagnoses, but late-stage cancer...

Aug 5, 2023